article thumbnail

Anthem Caps Coverage Of Biogen Spine Drug Despite Wide FDA Approval

Xconomy

One of the nation’s major health insurers has placed limitations on access to the first-ever approved drug for the rare spinal muscular atrophy, validating patient fears that the high price tag of the drug, nusinersen (Spinraza), might make it hard for some with the disease to get treatment.

Anthem 40
article thumbnail

Insurer UHC Will Cover Biogen Spine Drug, But With Limits And Proof

Xconomy

health insurer, UnitedHealthCare, has said it would cover the first-ever approved drug for the rare disease spinal muscular atrophy, a closely watched bellwether in the national debate over drug prices. Another major U.S.

Anthem 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This Week in VC with Farb Nivi, Founder of Grockit

Both Sides of the Table

Discussion: Had a long chat about PicClick , a company founded by Ryan Sit in San Diego. Pricing engine helps publishers ascertain ad inventory pricing by analyzing ad transaction data from the market/exchanges. Total raised: $5.3mm Read more: TechCrunch. __. They sponsor TWiVC. MetaMarkets. Hello, Chair.

article thumbnail

Interview with Derrick Oien, Intercasting

socalTECH

San Diego-based Intercasting (www.intercasting.com) is one of the companies which seems to have gotten some traction, and has deployed with Boost, Virgin, Sprint, and is in the process of deploying with Verizon and ATT. Derrick Oien: We have a platform we develop, called ANTHEM. Intercasting is backed by $17.5M

article thumbnail

Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug

Xconomy

But just after Christmas, she saw the price. More than a decade after his diagnosis, Mikhail only has the strength to take a few steps on his own. With the approval, Memedovich finally had hope. Cambridge, MA-based Biogen (NASDAQ: BIIB ), the drug’s. Read more » Reprints | Share:

Pricing 78
article thumbnail

Bio Roundup: Travel Ban, Pharma in D.C., Biogen Splits, PCSK9 Wins

Xconomy

At the same time, a handful of the industry’s top CEO’s flew to Washington for a meeting with the President, who promised to speed the drug approval process, lower drug prices, and overhaul the FDA. Meanwhile, the future of the Affordable Care Act remains undecided, and Tom Price’s controversial candidacy for the top healthcare.

Pricing 40
article thumbnail

Interview with Ramit Varma, Revolution Prep

socalTECH

Some of the biggest school districts, including LA Unified, San Diego, and Oakland all use our software. My brother is actually at Anthem Ventures, working with Bill Woodward, and I was an intern there in business school. Now, despite bootstrapping, you actually have some connections to the venture capital world, don't you?